In the News

igba global biosimilars week
November 15, 2020
IGBA launched the first ever Global Biosimilars Week, which is aimed at raising the awareness of biosimilar medicines worldwide through a globally aligned educational initiative.
Approved Biosimilars
November 11, 2020
The Association for Accessible Medicines looks forward to working with the incoming Biden-Harris administration to achieve our shared goal of increasing access to safe, effective and affordable generic and biosimilar prescription medicines for all Americans.
IQVIA Biosimilars in the US
October 6, 2020
Today’s IQVIA report confirms that biosimilars are gaining ground to the benefit of patients and the U.S. health care system, but also raises a red flag about the long-term sustainability of the biosimilar market.
August 6, 2020
Developers of generic and biosimilar medicines support diversification of the pharmaceutical supply chain and are working with policymakers to add to our significant manufacturing presence in the United States
increasing access to biosimilars act
July 2, 2020
The Biosimilars Council commends Senators Cornyn and Bennet for the introduction of the Increasing Access to Biosimilars Act.
Key Lessons for the US From EU
June 3, 2020
A new report from Matrix Global Advisors (MGA) details “lessons learned” from the European biosimilars experience that can improve access to these medicines for America’s patients.

Recent Tweets

Did you know the Biosimilars Council has a newsletter that includes the latest updates in the #biosimilars industry including policy movement, educational resources and upcoming events?

Subscribe to receive the Biosimilars Bulletin today:

Load More...